Is Graves' disease a form of hyperthyroidism or hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Graves' Disease is a Form of Hyperthyroidism

Graves' disease is definitively a form of hyperthyroidism characterized by overactivity of the thyroid gland, resulting in overproduction of thyroid hormones and increased metabolic rate. 1

Pathophysiology and Classification

Graves' disease is an autoimmune disorder and represents the most common cause of hyperthyroidism in iodine-sufficient areas. The key mechanism involves:

  • Autoantibodies (TSH receptor antibodies or TRAb) that bind to and stimulate the thyroid hormone receptor, causing unregulated thyroid hormone production 1, 2
  • Thyroid hypertrophy and overactivity resulting in excessive thyroid hormone secretion 3
  • Accounts for approximately 95% of hyperthyroidism cases in pregnancy 1

Clinical Manifestations

The clinical presentation of Graves' disease reflects its hyperthyroid state:

  • Systemic symptoms: Tremors, nervousness, insomnia, excessive sweating, heat intolerance, tachycardia, hypertension, and goiter 1
  • Ophthalmopathy: Occurs in approximately 50% of patients, with symptoms including eyelid lag or retraction 1, 4
  • Dermal manifestations: Including localized and pretibial myxedema 1

Diagnostic Confirmation

The diagnosis of Graves' disease as a hyperthyroid condition is confirmed by:

  1. Thyroid function tests:

    • Low or suppressed TSH (<0.45 mIU/L) 1
    • Elevated Free T4 and/or Free T3 levels 1
    • Some patients have normal FT4 but elevated FT3 (T3 toxicosis occurs in ~8-16% of hyperthyroid cases) 1
  2. Antibody testing:

    • Positive TSH receptor antibodies (TRAb) - the hallmark of Graves' disease 1, 3
    • May also have thyroid peroxidase antibodies (TPOAb) 1

Treatment Options

The FDA-approved treatments for Graves' disease further confirm its classification as hyperthyroidism:

  1. Antithyroid medications:

    • Methimazole is indicated "in patients with Graves' disease with hyperthyroidism" 5
    • Propylthiouracil can be used, particularly in the first trimester of pregnancy 6
    • These medications work by inhibiting thyroid hormone synthesis 7, 3
  2. Beta-blockers (e.g., propranolol) are used to control hyperthyroid symptoms 1, 7

  3. Definitive treatments:

    • Radioactive iodine ablation (RAIU)
    • Thyroidectomy (total or partial) 7, 3

Complications of Untreated Disease

The consequences of untreated Graves' disease further confirm its hyperthyroid nature:

  • Thyroid storm - a life-threatening hyperthyroid emergency 1
  • In pregnancy: increased risk of severe preeclampsia, preterm delivery, heart failure, and possibly miscarriage 1
  • Long-term cardiovascular complications related to persistent hyperthyroidism 1

Common Pitfalls to Avoid

  1. Confusing Graves' disease with other thyroid disorders:

    • Unlike Hashimoto's thyroiditis (which typically causes hypothyroidism), Graves' disease causes hyperthyroidism
    • However, patients treated for Graves' disease may develop hypothyroidism as a result of treatment 3
  2. Missing extrathyroidal manifestations:

    • Graves' ophthalmopathy can sometimes occur even when thyroid function is controlled 4
    • The presence of ophthalmopathy can influence treatment decisions 2
  3. Inadequate monitoring:

    • Patients with subclinical hyperthyroidism should be retested within 3 months (TSH 0.1-0.45 mIU/L) or within 4 weeks for TSH <0.1 mIU/L 1

In conclusion, Graves' disease is unequivocally a form of hyperthyroidism, as evidenced by its pathophysiology, clinical presentation, diagnostic findings, and treatment approaches.

References

Guideline

Thyroid Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of Graves disease: a global overview.

Nature reviews. Endocrinology, 2013

Research

Diagnosis and classification of Graves' disease.

Autoimmunity reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.